已收盘 10-30 16:00:00 美东时间
-0.015
-1.51%
Fractyl Health's market research highlights strong patient interest in Revita, a one-time endoscopic procedure for weight maintenance after GLP-1 therapy discontinuation. Approximately one million U.S. patients monthly stop GLP-1 medications, risking weight regain. One-third of surveyed GLP-1 users prefer a procedure over continued medication. Revita, designed to address post-GLP-1 weight maintenance, has shown promising results in clinical trial...
10-29 11:00
10月24日,Fractyl Health(GUTS)收跌4.42%,报1.08美元,成交额48.12万美元,市值1432.58万美元。 行情数据 • 开盘价...
10-24 07:55
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Fractyl Hea...
10-22 22:45
今日重点评级关注:HC Wainwright & Co.:维持Annexon"买入"评级,目标价从14美元升至25美元;HC Wainwright & Co.:维持Alto Neuroscience"买入"评级,目标价从55美元升至60美元
10-20 12:36
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:51
Fractyl Health Inc. (NASDAQ:GUTS) stock plunged nearly 50% in Friday’s trading despite the company reporting positive six-month clinical trial results for its Revita weight-loss treatment. The selloff comes as Fractyl faces an investor class action lawsuit over earlier trial disclosures and concerns...
10-16 22:01
The latest update is out from Fractyl Health, Inc. ( ($GUTS) ). On October 16, ...
10-16 19:39
REMAIN-1 met its six-month co-primary endpoint with high statistical significance (p=0.0023; mITT population); demonstrated 80% retention of GLP-1 induced weight loss vs 67% for sham 32% of Revita® participants in primary analysis population (mITT) were either weight stable or had further weight los...
10-16 19:02
Fractyl Health shares are trading lower after the company announced a 1-for-12 reverse stock split, effective October 2.
10-02 00:58
Fractyl Health, Inc. ( ($GUTS) ) just unveiled an update. On March 13, 2026, Fr...
09-12 04:52